TR199801862T2 - Kombinasyon preparatlari. - Google Patents

Kombinasyon preparatlari.

Info

Publication number
TR199801862T2
TR199801862T2 TR1998/01862T TR9801862T TR199801862T2 TR 199801862 T2 TR199801862 T2 TR 199801862T2 TR 1998/01862 T TR1998/01862 T TR 1998/01862T TR 9801862 T TR9801862 T TR 9801862T TR 199801862 T2 TR199801862 T2 TR 199801862T2
Authority
TR
Turkey
Prior art keywords
combination preparations
carbonacid
methylisoxazole
croton
anilide
Prior art date
Application number
TR1998/01862T
Other languages
English (en)
Inventor
Bartlett Robert
Then Johann
Original Assignee
Hoechst Aktiengesellchaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7788856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199801862(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Aktiengesellchaft filed Critical Hoechst Aktiengesellchaft
Publication of TR199801862T2 publication Critical patent/TR199801862T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

5-metilisoksazol-4-karbonasit- (4-triflormetil) -anilid ve N-(4-triflormetilfenil)-2-siyan-3-hidroksi-kroton asitamid içeren kati bir bilesim immunolojik hastaliklarin tedavisinde uygundur.
TR1998/01862T 1996-03-20 1997-03-07 Kombinasyon preparatlari. TR199801862T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19610955A DE19610955A1 (de) 1996-03-20 1996-03-20 Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid

Publications (1)

Publication Number Publication Date
TR199801862T2 true TR199801862T2 (tr) 1998-12-21

Family

ID=7788856

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01862T TR199801862T2 (tr) 1996-03-20 1997-03-07 Kombinasyon preparatlari.

Country Status (23)

Country Link
US (1) US7071222B2 (tr)
EP (1) EP0896537B1 (tr)
JP (1) JP4206131B2 (tr)
KR (1) KR100464693B1 (tr)
CN (1) CN1141095C (tr)
AT (1) ATE183393T1 (tr)
AU (1) AU705692B2 (tr)
BG (1) BG64189B1 (tr)
BR (1) BR9708108A (tr)
CY (1) CY2209B1 (tr)
CZ (1) CZ289446B6 (tr)
DE (2) DE19610955A1 (tr)
ES (1) ES2137055T3 (tr)
GR (1) GR3031637T3 (tr)
HK (1) HK1018742A1 (tr)
HU (1) HU226677B1 (tr)
NO (1) NO315595B1 (tr)
NZ (1) NZ331933A (tr)
PL (1) PL188052B1 (tr)
RU (1) RU2198655C2 (tr)
TR (1) TR199801862T2 (tr)
UA (1) UA46103C2 (tr)
WO (1) WO1997034600A1 (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355678B1 (en) * 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
DE19960443C2 (de) 1999-12-15 2002-05-08 Aventis Pharma Gmbh Verfahren zur Auffindung von Nukleotidsyntheseinhibitoren mit weniger Nebenwirkungen
HUP0204069A3 (en) * 1999-12-16 2005-01-28 Teva Pharma Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
CA2441088A1 (en) * 2001-03-13 2002-09-19 Protagen Ag 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof
DE10112924A1 (de) * 2001-03-13 2002-10-02 Erich Eigenbrodt 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate
DE10112925A1 (de) * 2001-03-13 2002-10-02 Erich Eigenbrodt Verwendung von Zuckerphosphaten, Zuckerphosphatanalogen, Aminosäuren, Aminosäureanalogen zur Modulation von Transaminasen und/oder der Assoziation p36/Malat Dehydrogenase
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
WO2003006424A1 (en) 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ATE450498T1 (de) 2002-12-23 2009-12-15 4Sc Ag Cycloalken-dicarbonsäure-verbindungen als entzündungshemmende, immunmodulatorische und antiproliferative mittel
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
EP2100881A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Pyrimidyl- or pyridinylaminobenzoic acid derivatives
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (en) * 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combination comprising DHODH inhibitors and methotrexate
EP2239256A1 (en) 2009-03-13 2010-10-13 Almirall, S.A. Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor
EP2314577A1 (en) 2009-10-16 2011-04-27 Almirall, S.A. Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid
US8686048B2 (en) 2010-05-06 2014-04-01 Rhizen Pharmaceuticals Sa Immunomodulator and anti-inflammatory compounds
UA108760C2 (uk) 2010-07-01 2015-06-10 Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби
EP2444086A1 (en) 2010-10-22 2012-04-25 Almirall, S.A. Combinations comprising DHODH inhibitors and COX inhibitors
US20140031383A1 (en) 2011-02-08 2014-01-30 Dana-Farber Cancer Institute, Inc. Methods for treatment of melanoma
CN103755592A (zh) * 2013-12-30 2014-04-30 镇江圣安医药有限公司 (2z)-氰基-3-羟基-n-[4-(三氟甲基)苯基]-2-丁烯酰胺的衍生物及其应用
WO2018136009A1 (en) 2017-01-20 2018-07-26 Aslan Pharmaceuticals Pte Ltd Combination therapy
US20210017125A1 (en) 2018-03-16 2021-01-21 Immunic Ag Novel calcium salt polymorphs as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
WO2021214033A1 (en) 2020-04-21 2021-10-28 Immunic Ag Vidofludimus for use in the treatment or prevention of viral diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268382A (en) 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
DK0527736T3 (da) * 1990-05-18 1997-10-20 Hoechst Ag Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler.
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
DE19908527C2 (de) * 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid

Also Published As

Publication number Publication date
NO984343L (no) 1998-09-18
CY2209B1 (en) 2002-11-08
CZ298598A3 (cs) 1998-12-16
AU705692B2 (en) 1999-05-27
CN1141095C (zh) 2004-03-10
EP0896537A1 (de) 1999-02-17
DE19610955A1 (de) 1997-09-25
RU2198655C2 (ru) 2003-02-20
BG64189B1 (bg) 2004-04-30
PL188052B1 (pl) 2004-12-31
NO984343D0 (no) 1998-09-18
US7071222B2 (en) 2006-07-04
WO1997034600A1 (de) 1997-09-25
CN1213302A (zh) 1999-04-07
HK1018742A1 (en) 2000-01-07
ATE183393T1 (de) 1999-09-15
HU226677B1 (en) 2009-06-29
EP0896537B1 (de) 1999-08-18
BG102697A (en) 1999-09-30
HUP9902130A3 (en) 2001-01-29
JP4206131B2 (ja) 2009-01-07
DE59700356D1 (en) 1999-09-23
ES2137055T3 (es) 1999-12-01
KR100464693B1 (ko) 2005-04-19
NZ331933A (en) 2000-06-23
PL328998A1 (en) 1999-03-01
US20020006945A1 (en) 2002-01-17
GR3031637T3 (en) 2000-02-29
AU1926197A (en) 1997-10-10
BR9708108A (pt) 1999-07-27
HUP9902130A2 (hu) 1999-11-29
KR20000064757A (ko) 2000-11-06
CZ289446B6 (cs) 2002-01-16
UA46103C2 (uk) 2002-05-15
NO315595B1 (no) 2003-09-29
JP2000510440A (ja) 2000-08-15

Similar Documents

Publication Publication Date Title
TR199801862T2 (tr) Kombinasyon preparatlari.
BR8704062A (pt) Silenciador e componente acustico
KR970704430A (ko) 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity)
DE3673273D1 (de) Prophylaktische und therapeutische mittel fuer kreislaufkrankheiten.
DE69520331T2 (de) Massenspektrometrie von Lösungen und Vorrichtung dafür
IT1213514B (it) Procedimento e dispositivo per la depurazione di gas di rigetto.
FI965204A0 (fi) Bromelaiinin lääkekäyttö
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
NO973826D0 (no) Ny anvendelse av preparater inneholdende perlemor
ID16219A (id) Dehidrogenasi alkohol siklik sekunder
TR25109A (tr) DüZ PARCALARIN TEKLESTIRILMESINE MAHSUS USUL VE TERTIBAT
FI963263A0 (fi) Bromelaiinin lääkinnällinen käyttö
ATE57526T1 (de) P-acylaminobenzamide.
IT1279073B1 (it) Procedimento e dispositivo per la regolazione della silezionsita' di funzionamento di un motore endotermico
DE69503929D1 (de) Behandlung von Gasmischungen
TR199802118A3 (tr) Egzoz gazlarinin aritilmasi için yöntem ve düzenleme.
FR2728596B1 (fr) Degrilleur, notamment du type courbe
DE9413058U1 (de) Ringförmiges Schmuckstück
KR950019457U (ko) 압축기의 소음기 체결장치
KR940016345U (ko) 밀폐형 압축기의 머플러 체결장치
KR940027038U (ko) 압축기의 소음기
ATE184487T1 (de) Transdermales therapeutisches system für silatranverbindungen
KR920019917U (ko) 흡, 배기 덕트의 단위체
KR890003053U (ko) 방사형 가스스토브의 좌, 우회전 장치
IT9067565A0 (it) Procedimento per la purificazione di gas di scarico, e apparecchiatura per la sua realizzazione